Drug Therapy For Diabetic Eye Disease Shows Promising Results In Clinical Trial

Wednesday, April 30, 2008

Comments

Medical News Today

A JDRF collaboration between Johns Hopkins researchers and Genentech has shown that a drug for the treatment of diabetic eye disease has performed better in clinical trials than the current standard treatment using laser surgery.

Full Story

Retina Products and Equipment »

The first day after trabeculectomy, a patient with primary open angle glaucoma presents with a bleb that is almost flat, a very shallow anterior chamber, and vision decreased from 20/30 to 20/100. The IOP is 1 to 2 mmHg. What is the most likely cause?
1. Aqueous misdirection (malignant glaucoma)
2. Pupillary block
3. Early failure of the bleb with episcleral fibrosis
4. Ciliary body shut down
5. Bleb leak
Check The Answer

SPECTRALIS Diagnostic Imaging Platform
A modular and upgradeable ophthalmic ... view product
Volk iNview
iPhone Fundus Camera The Volk iNview ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Drug Therapy For Diabetic Eye Disease Shows Promising Results In Clinical Trial

Comments

Related Categories

Retina Products and Equipment »

Quick Quiz

The first day after trabeculectomy, a patient with primary open angle glaucoma presents with a bleb that is almost flat, a very shallow anterior chamber, and vision decreased from 20/30 to 20/100. The IOP is 1 to 2 mmHg. What is the most likely cause?

AdGlare RMR Ad

Featured Products

SPECTRALIS Diagnostic Imaging Platform

Volk iNview

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us